AGUENNOUZ, M'hammed
 Distribuzione geografica
Continente #
NA - Nord America 5.827
EU - Europa 5.656
AS - Asia 1.097
Continente sconosciuto - Info sul continente non disponibili 11
SA - Sud America 11
OC - Oceania 6
AF - Africa 2
Totale 12.610
Nazione #
US - Stati Uniti d'America 5.809
IE - Irlanda 1.601
SE - Svezia 1.356
IT - Italia 936
CN - Cina 923
DE - Germania 485
UA - Ucraina 481
FI - Finlandia 260
GB - Regno Unito 171
PL - Polonia 131
IN - India 99
FR - Francia 98
BE - Belgio 72
VN - Vietnam 24
SG - Singapore 22
RU - Federazione Russa 20
AT - Austria 18
CA - Canada 18
IR - Iran 12
NL - Olanda 12
EU - Europa 8
CL - Cile 7
TW - Taiwan 5
AU - Australia 3
CO - Colombia 3
KR - Corea 3
NZ - Nuova Zelanda 3
PK - Pakistan 3
PT - Portogallo 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BG - Bulgaria 2
CH - Svizzera 2
GR - Grecia 2
IL - Israele 2
A1 - Anonimo 1
BR - Brasile 1
EG - Egitto 1
HR - Croazia 1
ID - Indonesia 1
IQ - Iraq 1
IS - Islanda 1
JP - Giappone 1
KH - Cambogia 1
LU - Lussemburgo 1
LV - Lettonia 1
MA - Marocco 1
NO - Norvegia 1
RO - Romania 1
Totale 12.610
Città #
Dublin 1.600
Chandler 1.114
Jacksonville 1.058
Nyköping 841
Beijing 395
Ashburn 305
Princeton 301
Messina 295
Medford 276
Ann Arbor 243
Cambridge 243
Des Moines 210
Dearborn 172
Warsaw 126
Boardman 112
Wilmington 79
Jinan 77
Shenyang 73
New York 70
San Mateo 66
Brussels 64
Woodbridge 63
Lancaster 60
Nanjing 48
Hyderabad 47
Bremen 45
Pune 37
Rome 37
Tianjin 37
Hebei 36
Ningbo 31
Zhengzhou 28
Taizhou 27
Caltagirone 26
Haikou 26
Dong Ket 24
Hangzhou 24
Norwalk 24
Seattle 24
Houston 22
Falls Church 21
Los Angeles 19
Palo Del Colle 18
Vienna 18
Nürnberg 17
Catania 16
Milan 16
Washington 16
Augusta 15
Guangzhou 15
Ottawa 15
Helsinki 14
Auburn Hills 12
Fuzhou 12
Nanchang 12
Mascali 11
Taiyuan 11
Changsha 10
Ardabil 9
Leawood 9
Rovereto 8
Monmouth Junction 7
Waanrode 7
Bari 6
Catanzaro 6
Jiaxing 6
Taranto 6
Torino 6
Gela 5
Genova 5
Lanzhou 5
Lappeenranta 5
Monopoli 5
Mumbai 5
Bologna 4
Chambéry 4
Fairfield 4
Hefei 4
London 4
Padova 4
Redwood City 4
San Jose 4
Anaheim 3
Bogotá 3
Chaoyang 3
Clearwater 3
Corleone 3
Cosenza 3
Florence 3
Fremont 3
Hanover 3
Kunming 3
Livorno 3
Northampton 3
Paris 3
Piazza Armerina 3
Pisa 3
Redmond 3
Saint Petersburg 3
Salerno 3
Totale 8.840
Nome #
Idrocefalo normoteso idiopatico (iNPH): nostra esperienza preliminare. 362
Severe rhabdomyolysis in a patient with “Heat Stroke” 192
MiRNA expression profiling regulates necroptotic cell death in hepatocellular carcinoma 124
PDXK mutations cause polyneuropathy responsive to pyridoxal 5'-phosphate supplementation. 105
Mutations in the Neuronal Vesicular SNARE VAMP2 Affect Synaptic Membrane Fusion and Impair Human Neurodevelopment 92
Prognostic value of HMGB1 and oxidative stress markers in multiple trauma patients: A single-centre prospective study 86
Hippo signaling pathway is altered in Duchenne muscular dystrophy 85
miRNA regulation of Sirtuin-1 expression in human astrocytoma 83
Characterization and functional analysis of the human microRNA 363 in glioblastoma transfected cell lines 81
MicroRNA signatures predict dysregulated Vitamin D receptor and calcium pathways status in Limb Girdle muscle dystrophies (LGMD) 2A/2B. 77
null 76
Modulation of neuronal nitric oxide synthase and apoptosis by the isoflavone genistein in Mdx mice 74
SIRT1 and SIRT2 Expression correlates with advanced disease and bone lesions in Multiple Myeloma 74
A NOVEL SERUM MICRORNA SIGNATURE TO SCREEN TRANSTHYRETIN-RELATED FAMILIAL AMYLOID POLYNEUROPATHY 71
The soy isoflavone genistein blunts nuclear factor kappa-B, MAPKs and TNF-α activation and ameliorates muscle function and morphology in mdx mice. 71
Role of inflammation and oxidative stress mediators in gliomas. 70
Type I hyperprolinemia and proline dehydrogenase (PRODH) mutations in four Italian children with epilepsy and mental retardation. 69
MDR-1 gene polymorphisms G2677T and C3435T in a case of Hodgkin's variant of Richter's syndrome 69
NLRP3 inflammasome CSF expression and neuropsychological changes in idiopathic normal pressure hydrocephalus 69
Circulating microRNAs Profile in Patients With Transthyretin Variant Amyloidosis 69
Expression of transglutaminase 2 does not differentiate focal myositis from generalized inflammatory myopathies 68
Clinical and genetic characterization in two families with muscle phosphofructokinase deficiency 68
Biallelic mutations in neurofascin cause neurodevelopmental impairment and peripheral demyelination 68
null 67
NF-kB blockade reduces skeletal muscle degeneration and enhances muscle function in mdx mice. 66
A Phase 1/2 Study of Flavocoxid, an Oral NF-κB Inhibitor, in Duchenne Muscular Dystrophy 66
ANT1 expression and RAGE-NF-kB pathway activation in sporadic inclusion-body myositis 65
Studio dell'espressione genica del muscolo scheletrico in pazienti affetti da glicogenosi II 64
Analisi dello stato di metilazione del promoter di O6-methylguanine DNA methyltransferase (MGMT) e TMS1/ASC: possibili implicazioni cliniche e prognostiche nei gliomi cerebrali diffusi di basso grado 64
Mutations in NKX6-2 Cause Progressive Spastic Ataxia and Hypomyelination 64
Miopatie metaboliche 63
A Nouvel serum MicroRNA signature to screen ATTR 63
Effect of exercise on telomere length and telomere proteins expression in mdx mice 63
4-Methyl umbelliferone effects on cell proliferation in human glioma cells. 63
Analisi dello stato di metilazione del promoter di O6-methylguanine DNA methyltransferase (MGMT) e TMS1/ASC nei gliomi cerebrali diffusi di basso grado: possibili implicazioni cliniche e prognostiche. 63
Modulazione della lunghezza telomerica nei diversi gradi di tumore astrogliale nell'uomo. 62
Pilot study of flavocoxid in ambulant DMD patients. 62
A multicenter, randomized, double-blind, placebo-controlled trial of long-term ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL): the study protocol 62
Autoimmunity to heterogeneous nuclear ribonucleoprotein A1 in psoriatic patients and correlation with disease severity 62
Telomere shortening and telomere-associated proteins in Duchenne muscular dystrophy. 61
ANT1 expression and RAGE-NF-kB pathway in sporadic inclusion body myositis. 61
Espressione differenziale di un panel di miRNA in tumori cerebrali astrogliali con diverso grado di malignità. 61
Dyscondrosteosis in a child with Becker muscular dystrophy: an unreported association between Xp21 gene (DMD/BMD) deletion and a novel homozygous SHOX gene mutation 60
Type I Hyperprolinemia Associated with Epilepsy and Mental Retardation Results from PRODH Gene Mutations in Three Sicilian Children. 60
Meccanismi antiapoptotici nf-kb-mediati in gliomi umani in vivo. 60
Expression of the tumor necrosis factor receptor-associated factors I and 2 and regulation of the nuclear factor-kappa B antiapoptotic activity in human gliomas 60
Advances in Treatment of ATTRv Amyloidosis: State of the Art and Future Prospects 60
Telomere shortening is associated to TRF1 and PARP1 overexpression in Duchenne muscular dystrophy 60
A cytochemical study of apoptosis in metabolic myopathies 59
EFFECT OF TREATMENT WITH PDTC AND IRFI 042 ON STRENGTH AND FATIGUE IN MDX MICE 58
RAGE, NF-kB and oxidative stress: role in FSHD pathogenesis. 58
Clinical and genetic charactherization in two families with muscle phosphofructokinase deficiency 58
Novel SHOX Gene Mutation in a Short Boy with Becker Muscular Dystrophy: Double Trouble in Two Adjacent Genes. 58
VEGF overexpression via adeno-associated virus gene transfer promotes skeletal muscle regeneration and enhances muscle function in mdx mice 58
Matrix Metalloproteinase 9 and Transglutaminase 2 Expression at the Ocular Surface in Patients with Different Forms of Dry Eye Disease 58
Pilot study of flavocoxid in ambulant DMD patients. 58
Asymptomatic hyperCKemia in a case of Danon disease due to a missense mutation in Lamp-2 gene 57
Expression of transglutaminase in myopathies 56
Clinical, biochemical and genetic features in muscle phosphofructokinase deficiency 56
Meccanismi anti-apoptotici nei gliomi. Ruolo dell'attività nucleare del nuclear factor-kb e dei suoi fattori di controllo. 56
Circulating miRNAs expression as potential biomarkers of mild traumatic brain injury. 56
Bi-allelic JAM2 Variants Lead to Early-Onset Recessive Primary Familial Brain Calcification 56
Evidence of calpain and caspase-3-like activation in CSF of severe human traumatic brain injury 55
Ruolo patogenetico dei microRNAs nelle calpainopatie 55
Detection of αII-Spectrin and Breakdown Products in Humans After Severe Traumatic Brain Injury 54
Fatal R631C mutation is also present in the adult form of CPTII deficiency 54
Espressione di ANT1 e attivazione della via RAGE-NF-kB nella miosite a corpi inclusi. 54
MiRNA expression profiling in human gliomas: upregulated miR-363 increases cell survival and proliferation 54
Clinical features and new molecular findings in Carnitine Palmitoyltransferase II (CPT II) deficiency 53
Dystrophin gene and SHOX gene mutations in a child with Becker muscular dystrophy and short stature 53
Activation of nuclear factor-kappa B in inflammatory myopathies and Duchenne muscular dystrophy 53
Modulation of neural nitric oxide synthase by the isoflavone genistein promotes muscle regeneration in mdx mice 53
ANT1 is reduced in sporadic inclusion body myositis. 53
Activation of nuclear factor-κB in inflammatory myopathies and Duchenne muscular dystrophy 52
Expression of telomeric repeat binding factor-1 in astroglial bran tumors 52
Expression of transglutaminase in myopathies 52
Calpain 3 deficiency in Quail Eater's disease 52
Telomere length modulation in astroglial brain tumors 52
Analysis of lipid profile in lipid storage myopathy 52
Severe rhabdomyolysis in a patient with “Heat Stroke” 52
Clinical hetrogeneity and molecular basis of myoadenilate deaminase deficiency 51
Inverse correlation between TRF-1 (telomeric-repeat binding factor 1) and histological grade of malignant brain tumors 51
Myoadenilate deaminase deficiency: clinical, histochemical and biochemical studies in primary and coincidental cases. 51
Immunohistochemical analysis of human skeletal muscle AMP deaminase deficiency. Evidence of a correlation between the muscle HPRG content and the level of the residual AMP deaminase activity 51
MDR-1 polymorphisms (G2677T and C3435T) in B-chronic lymphocytic leukemia: an impact on susceptibility and prognosis. 51
Ant1 expression and RAGE-NF-kB pathway activation in sporadic inclusion body myositis 51
A life threatening case of β-enolase deficiency 51
Activation and localization of transcription factor NF-KB in peripheral neuropathies of different origin. 51
Valutazione dell'influenza del polimorfismo del gene multi-drug resistance 1 (MDR1) e dell'espressione della P-glycoprotein (P-GP) sul decorso clinico e sulla sensibilità al trattamento steroideo nella sindrome nefrosica (SN) 50
Espressione del telomeric Repeat Binding Factor-1 (TRF-1) nei tumori cerebrali della serie astrogliale: possibili implicazioni clinico-terapeutiche. 50
Ruolo della proteolisi dell'alfa spectrina nei pazienti affetti da trauma cranico grave 49
Clinical heterogeneity and molecular basis of myoadenilate deaminase deficiency 49
Immunolocalization and activation of nuclear factor-kappa B in the sciatic nerves of rats with experimental autoimmune neuritis 49
Human astroglial tumors: transglutaminase 2 and retinoblastoma protein expression 49
Meccanismi antiapoptotici NF-kB-mediati in gliomi umani in vivo. 49
Transglutaminase 2 and its short isoform expression in human astroglial brain tumors 49
miR-21 and 221 upregulation and miR-181b downregulation in human grade II-IV astrocytic tumors 49
A case of vacuolar myopathy during the course of chronic hepatitis C. 48
NF-kB blockade reduces skeletal muscle degeneration and enhances muscle function in mdx. 48
RAGE-NF-kappa B pathway activation in response to oxidative stress in facioscapulohumeral muscular dystrophy 48
Totale 6.517
Categoria #
all - tutte 48.483
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.483


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201941 0 0 0 0 0 0 0 0 0 0 18 23
2019/20201.983 296 129 21 142 18 193 246 208 54 305 328 43
2020/20211.843 202 27 377 93 221 154 54 178 88 257 115 77
2021/20221.869 14 233 31 72 97 27 141 84 35 240 238 657
2022/20234.559 376 391 233 327 352 433 73 260 1.934 17 111 52
2023/20241.074 90 197 78 97 125 230 39 80 12 100 26 0
Totale 12.966